Carregant...
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury
BACKGROUND AND OBJECTIVES: Little is known about the comparative effects of dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs), or sodium glucose cotransporter-2 (SGLT2) inhibitors on risk of AKI. This study aimed to compare the effects of these three nov...
Guardat en:
| Publicat a: | Clin J Am Soc Nephrol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Nephrology
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792639/ https://ncbi.nlm.nih.gov/pubmed/33376101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11220720 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|